ConductScience.org, home

Library / Trial comparisons

Cases vs Controls (reference group): Risk of Anxiety Disorder Within Adult Patients With Vitiligo

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.01830.01540.0218wilsonClinicalTrials.gov
Risk in group 20.01540.01390.017wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.00295-0.0004150.00675newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.190.9741.46logClinicalTrials.gov
Odds ratio, group 1 over group 21.20.9731.47logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Cases than on Controls (reference group)339from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1CasesPatients with a confirmed diagnosis of Vitiligo within the study period will be included as cases for analysis.1226,655OG000ClinicalTrials.gov
Group 2Controls (reference group)The controls will be defined by matching cases with people who have never been diagnosed with vitiligo either prior to or during the study period, by age and sex, at General Practice level.38224,834OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypePRIMARYClinicalTrials.gov
TitleRisk of Anxiety Disorder Within Adult Patients With VitiligoClinicalTrials.gov
DescriptionAdjusted hazard ratio calclulated using Cox Proportional hazard modelsClinicalTrials.gov
Time frameWithin two years of vitiligo diagnosis. For matched controls, within two years of the date of diagnosis of their matched case.ClinicalTrials.gov
PopulationPatients with a pre-existing diagnosis of anxiety disorder were excluded from the analysisClinicalTrials.gov

Trial 8

FieldValueSource
TitleMental Health Associations With VitiligoClinicalTrials.gov
NCT numberNCT04953338ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsVitiligo, Depressive Episode, Recurrent Depressive Disorder, Anxiety Disorders, Social Phobia, Adjustment Disorders, Substance Abuse, Self-Harm, Deliberate, Overdose, Suicide, Attempted, ParasuicideClinicalTrials.gov
InterventionsExposure of mental health condtion of interestClinicalTrials.gov
Lead sponsorMomentum DataClinicalTrials.gov
Results first posted2025-12-02ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT04953338?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.